Precision Medicine
Entrepreneurs should focus on evidence to create businesses that provide personalized medicine
Conformis to sell, license some patient-specific instrumentation to Stryker
Conformis Inc. has entered into definitive agreements to sell and license certain assets relating to patient-specific instrumentation technology to Stryker Corporation, and to develop, manufacture and supply patient-specific instrumentation for use in connection with Stryker’s knee implant offerings.
Patients lack understanding of genomic results in Lung-MAP study
BARCELONA — Many participants in the Lung-MAP biomarker-driven clinical trial lacked understanding of genomic test results despite indicating they had adequate information on the benefits and risks of trial enrollment, according to study results presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.